Clinical Trial Update: A New Diagnostic Paradigm for Retinitis Pigmentosa Secondary to USH2A Pathogenic Variants

View source ↗

Summary

Clinical trial update describing a new diagnostic paradigm for Retinitis Pigmentosa caused by USH2A pathogenic variants; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Snippet

Sponsor: IRCCS Ospedale San Raffaele | Conditions: USH2A Variant Retinitis Pigmentosa | Status: NOT_YET_RECRUITING